Usage of the new edaravone free radical scavenger (XAVRON) in the treatment of acute ischemic stroke

Usage of the new edaravone free radical scavenger (XAVRON) in the treatment of acute ischemic stroke

The purpose of the study is to evaluate the effectiveness of use of the drug edaravone for treatment of patients with acute cerebral infarction comparing to citicoline.

The results of the treatment of ischemic stroke by intravenous administration of edaravone (Xavron) and citicoline indicated a more pronounced elimination of neurological deficit in the group edaravone.

13 January, 2020

Learn more

Uncategorized

Astenic syndrome in a post-covid-19 patient (review and own experience)

Among the symptoms and syndromes that dominate the clinical picture of postcoid syndrome (POST-COVID-19), the signs of asthenia, increased fatigue, excessive exhaustion during normal daily activities, which form asthenic syndrome, are highlighted. For the treatment of postcoid asthenic syndrome, a combination of pathogenetically justified agents has been proposed: podaravone (Xavron), a mixture of L-arginine and...
Uncategorized

” Long-haulers “: patients with post-covid syndrome in routine clinical practice

At the beginning of the COVID 19 pandemic, SARS-CoV 2 disease was thought to be transient (like most respiratory viral infections). The World Health Organization later reported that the duration of a new coronavirus disease from the onset of the first symptoms to mild clinical recovery is ≈2 weeks, and in severe or moderate cases,...
Uncategorized

The importance of non-motor symptoms in the clinical picture of motor neuron disease

Non-motor symptoms are an obligate sign of motor neuron disease and can often serve as a rather sensitive indicator of the general functional state of ALS patients. Gastrointestinal disorders, weight loss, pain, sweating and anxiety prevail in the structure of non-motor symptoms in ALS patients. The presence of non-motor symptoms in patients indicates the multisystemic...
Uncategorized

Modern possibilities of infusion therapy in patients with diabetic ketoacidosis

Summary. The mechanisms of development and clinical manifestations of diabetic ketoacidosis (DKA) are analyzed in the article, the infusion therapy program is presented, the prospects of the use of xylitol-based infusions in the treatment of DKA are discussed. The authors also presented their own experience with the use of Xylat solution. It has been shown...